Teresa De Nadai
Teresa obtained MSc in Neuroscience in 2010 from the Università degli Studi di Trieste (Italy) and a PhD in Neurobiology in 2015 from the Scuola Normale Superiore di Pisa (Italy).
She has more than ten years of experience in various sectors of the pharma industry and academic research laboratories. From 2016 to 2019 she has worked at Rivopharm Pharmaceuticals (Switzerland), first as Quality Assurance Officer, in the Quality Assurance Unit, and then as Stability Study Coordinator, in the Quality Control and Quality Assurance departments.
LIFTT Venture Capital Italia2023-03-10T14:46:48+01:00
LIFTT Venture Capital Italia2023-03-14T16:44:03+01:00
LIFTT Venture Capital Italia2023-03-14T16:43:15+01:00
LIFTT Venture Capital Italia2023-03-10T15:19:34+01:00
LIFTT Venture Capital Italia2023-03-14T16:43:35+01:00
LIFTT Venture Capital Italia2023-03-10T15:23:14+01:00